European Commission Approves Celltrion Healthcare's Vegzelma™ (CT-P16, biosimilar bevacizumab) for the Treatment of Multiple Types of Cancer
Press release content from Business Wire. The AP news staff was not involved in its creation.
United States New Orleans Donna Curran Bevacizumab Avastin Kevin Byoung Seo Choi American Association For Cancer Research
Source: apnews.com